<DOC>
	<DOCNO>NCT00859612</DOCNO>
	<brief_summary>There two major goal project : 1 . Comparison DXA QCT diagnosis bone loss CKD-5 patient determination prevalence low bone turnover CKD-5 patient bone loss . 2 . Identification optimal combination noninvasive test definition turnover component ROD .</brief_summary>
	<brief_title>Renal Osteodystrophy : A Fresh Approach</brief_title>
	<detailed_description />
	<mesh_term>Renal Osteodystrophy</mesh_term>
	<criteria>Aged 18 year old ; Chronic maintenance dialysis least 3 month ' duration ; Mental competence ; Willingness participate study ; Calcidiol level within normal range . Pregnancy ; Systemic illnesses organ disease may affect bone ( except type 1 type 2 diabetes mellitus ) ; Clinical condition may limit study participation ( e.g. , unstable angina , respiratory distress , infection ) . Chronic alcoholism and/or drug addiction ; Participation study investigational drug past 90 day ; Allergy tetracycline . Planning move area within 2 year study ; On active transplant list ; Treatment within last 6 month drug may affect bone metabolism ( except treatment calcitriol , vitamin D analog and/or calcimimetics ) . Calcidiol level normal range . The current routine clinical practice dialysis clinic check calcidiol status twice yearly supplement vitamin D accord serum calcidiol level . It therefore unlikely substantial number patient exclude due exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>